TrialThe oncologist2026

The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial.

Félix Guerrero-Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.